9-Me-BC (9-Methyl-β-carboline)
- Status
- Preclinical, , not approved for human use
- Evidence
Animal and cell only, graded on the Dopamine Pathway Bench
9-Methyl--carboline (9-Me-BC) is a synthetic -carboline alkaloid that has drawn nootropic-community interest for a preclinical property that is genuinely unusual among -carbolines: in rodent and cell-culture studies it appears to stimulate the dopaminergic phenotype - raising tyrosine hydroxylase, the number of differentiated dopamine neurons and dopamine content - while also showing neuroprotective, neurorestorative and anti-inflammatory effects, plus in-vitro MAO-A/MAO-B inhibition [PMID:17913302, PMID:20374418, PMID:32285253].
Reviewed
01Overview
What 9-Me-BC (9-Methyl-β-carboline) is
It is best understood as an experimental research chemical: there are no human trials, no human pharmacokinetic or safety data, and it is not approved for human use. Community dosing is entirely anecdotal, and because 9-Me-BC inhibits MAO-A it warrants MAOI-style caution. Research use only.
How it works
9-Me-BC is a synthetic 9-methylated -carboline (pyridoindole) alkaloid. Unlike most -carbolines, which tend to be neurotoxic, 9-Me-BC shows a distinctive dopaminergic-supportive profile in preclinical models, acting through several linked mechanisms:
Dopaminergic stimulation: up-regulates tyrosine hydroxylase and TH-relevant transcription factors (e.g. Nurr1, Pitx3, En1, Gata2/3, Creb), increasing the number of differentiated dopaminergic neurons and promoting neurite outgrowth in mesencephalic culture [PMID:17913302, PMID:20374418]. Raises dopamine tone: increases dopamine content in vitro and, in rats, elevates hippocampal dopamine alongside dendritic and synaptic proliferation that tracks with improved spatial learning [PMID:22380576]. Neuroprotection / neurorestoration: protects dopaminergic neurons against toxins (LPS, MPP+, rotenone), lowers -synuclein and apoptotic signaling, and in vivo restores dopamine, substantia-nigra neuron counts and mitochondrial complex I activity while inducing neurotrophins (BDNF, CDNF, CNTF, artemin) [PMID:20374418, PMID:20360614, PMID:32285253]. Anti-inflammatory: inhibits microglial proliferation and lowers inflammatory cytokines in the CNS [PMID:20374418]. MAO inhibition: inhibits MAO-A (IC50 ~1 uM) and MAO-B (IC50 ~15.5 uM) in vitro, and stimulates astrocyte neurotrophic-factor expression through a PI3K pathway; cellular uptake appears mediated partly by organic cation transporters [PMID:32285253]. This MAO-A inhibition is the basis for treating 9-Me-BC with MAOI-style interaction caution.
Read the full mechanismShow less
Important: every mechanism above is from rodent or cell-culture work. There is no evidence that 9-Me-BC is a phosphodiesterase inhibitor, that it is primarily a serotonergic agent, or that it drives melanogenesis/phototoxicity, and none of these mechanisms has been confirmed in humans. RUO.
Studied for
- Parkinson's disease
- Dopaminergic neurodegeneration
- Depression
- Cognitive enhancement
Benefits listed
- Preclinical dopaminergic support: in rodent and cell-culture studies 9-Me-BC increased tyrosine hydroxylase expression and the number of differentiated dopamine neurons [PMID:17913302, PMID:20374418]
- Cognitive/learning signal in rodents: 10 days of dosing improved spatial learning and raised hippocampal dopamine with dendritic and synaptic growth in rats [PMID:22380576]
- Neuroprotective/neurorestorative in animal Parkinson's models: restored dopamine and substantia-nigra neuron counts after MPP+ injury and boosted mitochondrial complex I activity [PMID:20360614]
- Anti-inflammatory and neurotrophic actions in preclinical models: reduced microglial activation and induced neurotrophic factors such as BDNF, CDNF and artemin [PMID:20374418, PMID:32285253]
Show 1 moreShow less
- Community-reported (anecdotal, unverified) motivation, drive, focus and mood lift - not demonstrated in any human study
What to expect
- This is a preclinical research chemical: all mechanistic and efficacy evidence comes from rodent and cell-culture work by a small number of research groups - there are zero human trials.
- Community users describe a stimulant-like lift in focus, motivation and mood, often the same day; these reports are anecdotal and unverified.
- Onset and half-life in humans are unknown, so the timing and duration of any effect cannot be stated reliably.
- Because it inhibits MAO-A in vitro, users treat it with MAOI-style caution: no serotonergic-drug stacking and mind tyramine-rich foods.
- No long-term human safety data exist - the honest expectation is uncertainty.
Individual responses vary. Timeline based on commonly reported research observations.
02Research
Free with emailWhat the research shows
Graded on a research bench
Reference pages that put 9-Me-BC (9-Methyl-β-carboline) next to the compounds people pair it with: roles, evidence, overlap and conflicts. No dosing. Research use only.
Unlock the research summary
Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.
- A summary of the key research
- Safety and side effects
- A link to the PubMed results
You also get the free peptide cheat sheet by email. Unsubscribe anytime.
Have an account? Sign in
03Safety
9-Me-BC side effects and interactions
Side effects
Risk not establishedStop use if
- Do not combine with SSRIs, SNRIs, MAOIs, MDMA or other serotonergic drugs
- Avoid in pregnancy/breastfeeding and with cardiovascular or liver disease
- Discontinue and seek care if signs of serotonin toxicity (agitation, rapid heartbeat, high temperature, tremor) occur
Common
- Insomnia if dosed late in the day (anecdotal)
- Overstimulation, anxiety or headache at higher intakes (anecdotal)
Less common
- Theoretical serotonin toxicity if combined with SSRIs/SNRIs/MAOIs or other serotonergic agents (based on in-vitro MAO-A inhibition, IC50 ~1 uM [PMID:32285253])
- Theoretical hypertensive (tyramine) reaction with aged/fermented foods due to MAO-A inhibition
Who should not use it
Contraindications
Precautionary (there is no human data to define true contraindications): avoid combining with SSRIs, SNRIs, MAOIs, other serotonergic drugs, or sympathomimetic stimulants due to 9-Me-BC's in-vitro MAO-A inhibition and the theoretical serotonin-toxicity / hypertensive (tyramine) risk. Not for use in pregnancy or breastfeeding, in anyone with significant cardiovascular or hepatic disease, or alongside prescription medications, given the complete absence of human safety testing. Research use only - not for human consumption.
Interactions
4 pairings in our record: 1 to avoid and 3 with a caution.
SSRIs
Avoid9-MBC has MAO-inhibiting properties — serotonin syndrome risk
Bromantane
CautionBoth improve dopamine — risk of excessive dopaminergic stimulation
Sulbutiamine
CautionBoth affect dopamine — monitor for overstimulation
Phenylpiracetam
CautionCombined stimulatory effects may cause anxiety
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
Need bloodwork before starting?
Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount.
04Dosing
Free with email9-Me-BC dosage and protocols
- Dose range
- Community/anecdotal only: ~5-25 mg per day, oral. No validated or approved human dose exists.
- Dosing
- Typically once daily (morning) in community reports; frequently cycled rather than taken continuously.
Unlock the dosing protocols
Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.
- Route and how often
- A titration schedule
- Beginner, intermediate and advanced protocols
- Reconstitution and handling notes
You also get the free peptide cheat sheet by email. Unsubscribe anytime.
Have an account? Sign in
05Prices
9-Me-BC (9-Methyl-β-carboline) prices
1 listing from 1 vendor, opening in the Featured order.
- Pack prices
- $54.99
- Lowest per mg
- Not listed
- Vendors
- 1
- Listings
- 1 (capsule)
Prices as the vendors list them, last recorded 22 September 2026.
| Vendor | Product | Price | Buy |
|---|---|---|---|
9-Me-BC capsule, 1 bottle In stock | $54.99 No mg count | Buy 9-Me-BC at BHG Labs |
Vendors selling 9-Me-BC (9-Methyl-β-carboline)(1: trust score, certificates, payment, shipping)
- BHG Labs1 listing, from $54.99
Trust Score 100/100, 41 of 43 certificate records read, pays by card, crypto, ships to the US
Every supplier above is graded 0 to 100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank. How we score these vendors
06Chemistry
Chemistry and structure
- Molecular formula
- C12H10N2
- Molecular mass
- 182.22 g/mol
- CAS number
- 2521-07-5
- IUPAC name
- 9-methyl-9H-pyrido[3,4-b]indole
08Questions
Frequently asked questions
Is 9-Me-BC safe for humans?
Unknown. There are no human safety studies, no clinical trials and no human pharmacokinetic data - every safety statement about 9-Me-BC is extrapolated from rodent/cell-culture work or from community anecdote. It is a research chemical (RUO), not an approved supplement or drug.
Is 9-Me-BC an MAO inhibitor?
In vitro, yes - it inhibits MAO-A with an IC50 around 1 uM and MAO-B around 15.5 uM [PMID:32285253]. That potency is why the community treats it with MAOI-style caution: avoid stacking it with SSRIs/SNRIs, other MAOIs or serotonergic supplements, and be mindful of tyramine-rich (aged/fermented) foods. These interactions are theoretical for 9-Me-BC specifically - they have not been formally documented in people.
What does the research actually show?
Dopaminergic, neuroprotective, neurorestorative and anti-inflammatory effects in rodents and cell cultures - including improved spatial learning and higher hippocampal dopamine in rats [PMID:22380576] and restoration of dopamine neurons in an MPP+ Parkinson's model [PMID:20360614]. None of this has been reproduced in humans, so it cannot be assumed to translate.
How do people dose it?
Anecdotally, roughly 5-25 mg once daily by mouth, usually in the morning and often cycled rather than taken continuously. There is no validated human dose - these figures come from nootropic forums, not clinical dosing studies.
Can I take it with my antidepressant?
You should not combine 9-Me-BC with SSRIs, SNRIs, MAOIs or other serotonergic medications. Because it inhibits MAO-A in vitro, combining it with serotonergic drugs carries a theoretical risk of serotonin toxicity. Talk to a clinician; do not self-combine.
Is 9-Me-BC approved or legal as a supplement?
No. It is not an approved drug or dietary supplement and is sold only as a research chemical for laboratory use (RUO). Legal status varies by country.
How many vendors sell 9-Me-BC (9-Methyl-β-carboline), and what does it cost per mg?
1 of the vendors BodyHackGuide tracks list 9-Me-BC (9-Methyl-β-carboline) (1 listing). The lowest listed price BodyHackGuide has recorded for 9-Me-BC (9-Methyl-β-carboline) is $54.99. No 9-Me-BC (9-Methyl-β-carboline) listing recorded as in stock carries a milligram count, so BodyHackGuide states no price per milligram for 9-Me-BC (9-Methyl-β-carboline).
Which vendors have third-party COAs for 9-Me-BC (9-Methyl-β-carboline) on file at BodyHackGuide?
BodyHackGuide holds no third-party certificate records for 9-Me-BC (9-Methyl-β-carboline). Each vendor page on BodyHackGuide shows how many certificate records BodyHackGuide holds for that vendor.
Free 2026 Peptide Cheat Sheet (PDF)
38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.
